Pillar · Biotech Investing
Biotech Due Diligence Checklist: How to Evaluate a Drug Pipeline and Probability of Approval
Most biotech investors skip due diligence and pay the price. This step-by-step checklist walks you through everything yo...
Start here
Pillar · Clinical Readouts
How to Read Biotech Clinical Trial Data: Phase 1, 2, 3 Results Explained for Investors
Clinical trial data is the single most important factor in biotech investing, but most investors struggle to read it. Th...
FDA & PDUFA Calendar
Biotech Catalysts to Watch: Key Developments for 2026 and Beyond
In 2026, 4 biotech catalysts to watch are poised to impact the market, including TLSA's Foralumab and CLDI's CLD-401. Key dates and insights inside....
FDA & PDUFA Calendar
Biotech Catalysts to Watch: Key Opportunities Ahead
On July 20, 2026, we highlight 4 biotech catalysts with varying probabilities of approval, including OTLK's ONS-5010 and TLSA's foralumab....
FDA & PDUFA Calendar
FDA Calendar: Upcoming PDUFA Dates and Drug Approval Decisions
As of Q3 2026, we analyze critical upcoming FDA approvals, focusing on their potential impact on the market and investor sentiment....
FDA & PDUFA Calendar
Biotech Penny Stock Catalysts: FDA Calendar and PDUFA Dates for Small-Cap Pharma Stocks
On July 17, 2026, we analyze biotech penny stock catalysts, including OTLK's ONS-5010 and TLSA's foralumab, with significant upcoming FDA decisions....